U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
178371178371Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal AdenocarcinomaCompletedNo Results AvailableAdenocarcinoma of OesophagusDrug: epirubicin, capecitabine, cisplatin|Procedure: Surgical resectionhttps://ClinicalTrials.gov/show/NCT00220103
178372178372DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)CompletedNo Results AvailableIrritable Bowel SyndromeDrug: dexloxiglumidehttps://ClinicalTrials.gov/show/NCT00220090
178373178373Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal CancerRecruitingNo Results AvailableOesophageal CancerProcedure: Endoscopyhttps://ClinicalTrials.gov/show/NCT00220077
178374178374A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI TumoursCompletedNo Results AvailableUpper Gastrointestinal TumoursDrug: Irinotecan, 5-Fluorouracil, Leucovorinhttps://ClinicalTrials.gov/show/NCT00220064
178375178375A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal CancerCompletedNo Results AvailableRectal CancerDrug: Oxaliplatin, Capecitabine|Procedure: Pre operative radiotherapy|Procedure: Surgical Resectionhttps://ClinicalTrials.gov/show/NCT00220051
178376178376Experiments to Test How and Why the Sense of Smell Differs Between PeopleCompletedNo Results AvailableSpecific AnosmiasBehavioral: smell testshttps://ClinicalTrials.gov/show/NCT00220038
178377178377Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.CompletedNo Results AvailablePsoriasis VulgarisDevice: Phototherapyhttps://ClinicalTrials.gov/show/NCT00220025
178378178378Effect of Folate on Colon and Blood CellsCompletedNo Results AvailableSubjects Will Have a Pre-cancerous Colorectal Polyp|Family Member Has History of Colorectal Adenoma of AdenocarcinomaProcedure: Folate depletion and supplementationhttps://ClinicalTrials.gov/show/NCT00220012
178379178379Hepatitis C Virus and the Humoral Immune SystemCompletedNo Results AvailableHepatitis C Virushttps://ClinicalTrials.gov/show/NCT00219999
178380178380Phase I/II, Open-Label Trial of Three Monoclonal AntibodiesCompletedNo Results AvailableHIV InfectionsDrug: Potent HAART during acute or early HIV-1 infectionhttps://ClinicalTrials.gov/show/NCT00219986
178351178351A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder SyndromeCompletedNo Results AvailableOveractive Bladder SyndromeDrug: SPM 907https://ClinicalTrials.gov/show/NCT00220363
178352178352Lupron Sex Offender TherapyActive, not recruitingNo Results AvailablePedophiliaDrug: leuprolide acetatehttps://ClinicalTrials.gov/show/NCT00220350
178353178353A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic NeuropathyCompletedNo Results AvailablePainful Diabetic NeuropathyDrug: lacosamidehttps://ClinicalTrials.gov/show/NCT00220337
178354178354Pearl Index Study With Low Dose Combined Oral ContraceptiveCompletedNo Results AvailableContraceptionDrug: Minisiston (SH D00342A)https://ClinicalTrials.gov/show/NCT00220324
178355178355A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or ThrombocytopeniaCompletedNo Results AvailableLeukemia, Lymphocytic, Chronic, B-CellDrug: Fludarabine Phosphate (Fludara)https://ClinicalTrials.gov/show/NCT00220311
178356178356Assessment of Long Term Treatment With Testosterone Undecanoate in Males With HypogonadismCompletedNo Results AvailableHypogonadismDrug: Testosterone undecanoate (TU) - NebidoTMhttps://ClinicalTrials.gov/show/NCT00220298
178357178357Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's LymphomaCompletedNo Results AvailableNon-Hodgkin's Lymphoma|Lymphoma, B-Cell|Lymphoma, Low-GradeDrug: Zevalin (SH L 749 , BAY86-5128)|Drug: Zevalin (SH L 749 , BAY86-5128)https://ClinicalTrials.gov/show/NCT00220285
178358178358Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's DiseaseCompletedNo Results AvailableParkinson DiseaseDrug: SR57667Bhttps://ClinicalTrials.gov/show/NCT00220272
178359178359Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)CompletedNo Results AvailableCystic FibrosisDrug: Fluticasone or placebohttps://ClinicalTrials.gov/show/NCT00220259
178360178360Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal CancerActive, not recruitingNo Results AvailableColorectal Neoplasmshttps://ClinicalTrials.gov/show/NCT00220246
178361178361Olmesartan as an Add-on to Amlodipine in HypertensionCompletedNo Results AvailableEssential HypertensionDrug: olmesartan medoxomil|Drug: amlodipine|Drug: hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT00220233
178362178362Amlodipine as Add-on to Olmesartan in HypertensionCompletedNo Results AvailableEssential HypertensionDrug: olmesartan medoxomil|Drug: amlodipinehttps://ClinicalTrials.gov/show/NCT00220220
178363178363Determining the Effect on Patients of Internet-Based Diabetes Disease ManagementCompletedNo Results AvailableDiabetes Mellitus, Type 2Behavioral: Internet co-management modulehttps://ClinicalTrials.gov/show/NCT00220207
178364178364A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate CancerCompletedNo Results AvailableCancer of ProstateDrug: leuprolide acetatehttps://ClinicalTrials.gov/show/NCT00220194
178365178365Prospective Study in Pelvic Radiotherapy PatientsCompletedNo Results AvailableGynaecological, Urological or Rectal Cancerhttps://ClinicalTrials.gov/show/NCT00220181
178366178366Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI TumoursCompletedNo Results AvailableUpper Gastrointestinal TumoursDrug: Irinotecan, Capecitabinehttps://ClinicalTrials.gov/show/NCT00220168
178367178367Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00220155
178368178368Molecular Markers of Prognosis in Colorectal Cancer PatientsCompletedNo Results AvailableColorectal Cancerhttps://ClinicalTrials.gov/show/NCT00220142
178369178369Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the OesophagusCompletedNo Results AvailableOesophageal CarcinomaDrug: Epirubicin, Cisplatin, Capecitabine|Procedure: Surgical Resectionhttps://ClinicalTrials.gov/show/NCT00220129
178370178370Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: Capecitabine, Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00220116

* Görseller ve İçerik tekif hakkına sahip olabilir